 Solution

For the nonbiology fabrication objective, reduce unwanted dipolar coupling while preserving a useful single-particle dynamic response. Lithographically reduce magnetic volume or adjust aspect ratio to control $\mu \simeq M_{s}V$ and magnetic anisotropy. Reducing $V$ reduces the characteristic pair interaction approximately as $V^2/r^3$, but also changes $E_a$ and relaxation time.

A nonmagnetic spacer coating or stable surface layer can maintain minimum center-to-center separation after release and reduce aggregation. At a fixed magnetic volume fraction this geometric constraint has a real packing cost; separation cannot be increased without limit while claiming unchanged loading.

Tune particle volume, magnetic anisotropy and spacing together, then measure dynamic susceptibility/loop area at the specified temperature and frequency. In a simple single-relaxation model, useful phase lag occurs near $\omega \tau \sim 1$; making particles so small that reversal is essentially instantaneous can reduce dissipative response. Clinical treatment optimization remains user-deferred; these are materials/fabrication controls, not a treatment recommendation.